Pfizer Announces Promising Data On Kids; FDA Limits Booster Shot Approval

Published on 20 Sep 2021, 22:27
Pfizer announced Monday that its covid vaccine was safe and highly effective in five-to-eleven-year-old children, and that the company planned to submit the data to the FDA for emergency use authorization. Meanwhile, news came out last week that the FDA had only approved booster shots for those who had received the Pfizer shot and were 65 years old or older, or at high risk of developing severe COVID symptoms. To discuss these developments and what it means for the year-and-a-half-long pandemic, Jim Braude was joined by Dr. Vanessa Kerry, director of the Global Public Policy & Social Change program at Harvard Medical School.